Results 161 to 170 of about 51,741 (305)

Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

Human Vaccines & Immunotherapeutics, 2022
We evaluated the immunogenicity and reactogenicity of heterologous COVID-19 primary schedules involving BNT162b2 (Pfizer-BioNTech), ChAdOx1 nCoV-19 (AstraZeneca) and CoronaVac (Sinovac) in healthy adults, as well as booster response to BNT162b2 following
Suvimol Niyomnaitham, Zheng Quan Toh, Patimaporn Wongprompitak, Laddawan Jansarikit, Kanjana Srisutthisamphan, Sompong Sapsutthipas, Yuparat Jantraphakorn, Natthakarn Mingngamsup, Paul V Licciardi, Kulkanya Chokephaibulkit   +9 more
doaj   +1 more source

Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine [PDF]

, 2022
Claudia Gandolfo, Gabriele Anichini, Marco Mugnaini, Monica Bocchia, Chiara Terrosi, Anna Sicuranza, Gianni Gori Savellini, Alessandro Gozzetti, Federico Franchi, Maria Grazia Cusi   +9 more
openalex   +1 more source

Humoral and functional SARS‐CoV‐2‐specific T‐cell responses elicited in chronic lymphocytic leukaemia patients with GEO‐CM04S1 a synthetic MVA‐vectored COVID‐19 vaccine

British Journal of Haematology, EarlyView.
Sandra Ortega‐Francisco, Maria Teresa Prudente de Aquino, Corinna La Rosa, Flavia Chiuppesi, Miguel‐Angel Gutierrez, Jacqueline Miller, Jing Li, Jada Mack‐Onyeike, Yifei Zhou, Qiao Zhou, Teodora Kaltcheva, Angela Patterson, Shannon Dempsey, Sandra Thomas, Katrin Tiemann, Dongyun Yang, Wasima Rida, Felix Wussow, Kelly McKee, Randy Taplitz, Erica Raiden, Tanya Siddiqi, Steven Rosen, Don J. Diamond, Alexey Danilov   +24 more
wiley   +1 more source

Polyphenol‐Mediated Engineering of Lipid Nanoparticles With Crystalline Mesophases

Advanced Materials, Volume 38, Issue 6, 27 January 2026.
A polyphenol‐mediated strategy enables the one‐step formation of lipid nanoparticles with nonlamellar mesophases, including micellar cubic and hexagonal structures. These highly ordered nanostructures accommodate a wide range of cargos—from metal ions to mRNA—and offer a modular and versatile platform for constructing functional lipid‐based delivery ...
Shiyao Li, Patrick Charchar, Haitao Yu, Zhixing Lin, Hamish G. Brown, Wanjun Xu, Chan‐Jin Kim, Irene Yarovsky, Yi Ju, Frank Caruso   +9 more
wiley   +1 more source

Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial

Vaccines
Vaccination remains an important mitigation tool against COVID-19. We report 1-month safety and preliminary immunogenicity data from a substudy of an ongoing, open-label, phase 2/3 study of monovalent Omicron XBB.1.5-adapted BNT162b2 (single 30-μg dose).
Juleen Gayed, Oyeniyi Diya, Francine S Lowry, Xia Xu, Vishva Bangad, Federico J. Mensa, Jing Zou, Xuping Xie, Yanping Hu, Claire Lu, Mark Cutler, Todd J Belanger, David Cooper, K. Koury, A. Anderson, Ö. Türeci, U. Şahin, K. Swanson, K. Modjarrad, A. Gurtman, N. Kitchin   +20 more
semanticscholar   +1 more source

Effectiveness of Comirnaty® Vaccine and Correlates of Immunogenicity and Adverse Reactions: A Single-Center Prospective Case Series Study [PDF]

[EN] The literature suggests that real-world data on the effectiveness and safety of the BNT162b2 vaccine depend on the characteristics of the vaccinated volunteers.
Fernández Lázaro, Diego, Garrosa, Evelina, Garrosa, Manuel, Jiménez Callejo, Elena, Mielgo Ayuso, Juan, Pardo Yanguas, María Dolores, Seco Calvo, Jesús Ángel, Sánchez Serrano, Nerea   +7 more
core   +1 more source

Unique Aerofoil‐Structured Microfluidics for High Throughput Lipid Nanoparticle Formulation Screening and Scale‐up

Advanced Science, Volume 13, Issue 6, 30 January 2026.
This study presents aerofoiled microfluidic structures optimized for efficient mixing and lipid nanoparticle (LNP) formation across broad flow rates. Based on this design, two dedicated systems are introduced: MiNANO‐form for high‐throughput formulation screening and MiNANO‐scale for continuous large‐scale production, enabling reproducible, high ...
Dongsheng Liu, Mingzhi Yu, Yuguo Zhang, Allen Mathew, Tianyu Guan, Liang Yao, Xianqing Wang, Wenxin Wang, Nan Zhang   +8 more
wiley   +1 more source

Erythema Multiforme after BNT162b2 Vaccination

Internal Medicine, 2022
Katayama, Sho, Ota, Mitsuhito
openaire   +2 more sources

Replacing Helper Lipids With Cationic Lipids Enhances mRNA Lipid Nanoparticles Stability in Solution

Advanced Science, Volume 13, Issue 3, 14 January 2026.
Partial Replacement of phospholipid lipid by cationic lipid improves storage stability of commercial mRNA LNPs by stabilizing their internal microstructure. Abstract Messenger RNA lipid nanoparticles (mRNA‐LNPs) have achieved remarkable success in clinical vaccination efforts to curb the COVID‐19 pandemic, and have attracted tremendous interest from ...
Rui Chen, Letao Xu, Nan Zhang, Haitao Yu, Xing Wang, Jiali Zhai, Fiona Whelan, Phillip Elliott, Chun‐Xia Zhao   +8 more
wiley   +1 more source

Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

New England Journal of Medicine, 2022
Dror Mevorach, Emilia Anis, Noa Cedar, Tal Hasin, Michal Bromberg, Lital Goldberg, Elchanan Parnasa, Rita Dichtiar, Yael Hershkovitz, Nachman Ash, Manfred S. Green, Lital Keinan-Boker, Sharon Alroy-Preis   +12 more
openaire   +4 more sources